Similar articles

• Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases.

  Cabriales S, Bresnahan J, Testa D, Espina BM, Scadden DT, Ross M, Gill PS. Cabriales S, et al. Oncol Nurs Forum. 1998 Jan-Feb;25(1):67-70. Oncol Nurs Forum. 1998. PMID: 9460774
• Liposomal daunorubicin is not recommended in patients with less than advanced HIV-related Kaposi's sarcoma.

  White RM. White RM. AIDS. 1997 Sep;11(11):1412-3. AIDS. 1997. PMID: 9302461 No abstract available.
• Chest discomfort associated with liposomal amphotericin B: report of three cases and review of the literature.

  Johnson MD, Drew RH, Perfect JR. Johnson MD, et al. Pharmacotherapy. 1998 Sep-Oct;18(5):1053-61. Pharmacotherapy. 1998. PMID: 9758315 Review.
• [Administration of liposomal preparation of DaunoXome for breast cancer in patients with poor prognosis].

  Darskaia EI, Zubarovskaia LS, Afanas'ev BV. Darskaia EI, et al. Vopr Onkol. 1999;45(4):440-4. Vopr Onkol. 1999. PMID: 10532108 Clinical Trial. Russian.
• [Prevention of anthracycline cardiotoxicity].

  Rossetti R. Rossetti R. Suppl Tumori. 2004 Jul-Aug;3(4):S117-9. Suppl Tumori. 2004. PMID: 15206234 Review. Italian. No abstract available.